Want to see DDD full AI Analyst Report?
Earnings Data
Report Date
Aug 10, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.05Last Year’s EPS
-0.07Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed meaningful operational and financial improvement: revenue grew 11% year-over-year, Healthcare grew 21%, Aerospace & Defense grew over 20%, gross margin expanded ~6 points, OpEx fell 35% and adjusted EBITDA turned positive in Q1. Management highlighted successful new product launches (NextDent 300), regulatory approvals, an expanding order backlog and an 80,000 sq ft capacity expansion. Cautions included regional supply-chain/logistics disruptions tied to the Middle East conflict, a temporary key-customer disruption (now resolved), modest FX/tariff headwinds and a conservative Q2 outlook ($93M–$95M revenue; adjusted EBITDA loss $2M–$4M). Overall, the positives — broad-based revenue growth, margin and expense improvements, strong product momentum and clear cost reductions — outweigh the short-term operational headwinds and cautious near-term guidance.Company Guidance
Return to Revenue Growth
Consolidated revenue of $95.5M in Q1, up 11% year-over-year, marking a solid return to top-line growth driven by key markets (Med Tech, Dental, Aerospace & Defense).
Healthcare Segment Outperformance
Healthcare Solutions revenue grew 21% year-over-year to $50.1M and was the larger segment in the quarter, led by printer, material sales and medical parts (notably titanium spinal and joint implants).
Aerospace & Defense Momentum
Aerospace & Defense delivered over 20% year-over-year growth within Industrial Solutions, supporting expectation of >20% growth in the Aero & Defense market for 2026 (~$35M).
Product and Materials Growth
Printers, materials and parts manufacturing each posted double-digit year-over-year growth; Dental material sales grew strongly (aligners and Vertex prosthetic materials) and metal printer sales increased, including DMP 350 traction.
Very Successful New Product Launch (NextDent 300)
NextDent 300 jetted denture solution has strong commercial reception (e.g., ROE Dental Labs tripled capacity), U.S. regulatory approval in 2025 and EU Phase IIa approval 2 months ahead of plan; addressable market expanded to >60M edentulous patients.
Gross Margin and Cost Savings
Non-GAAP gross margin improved to 36.1%, up ~6 percentage points year-over-year (adjusted), driven by better manufacturing absorption, favorable consumables mix and improved printer margins. Delivered >$55M in annualized cost savings to date.
Operating Expense Reduction and R&D Transition
First quarter non-GAAP operating expenses were $36.6M, down 35% ($20.1M) year-over-year (adjusted for divestitures); R&D-heavy product refreshes largely complete and company expects a transition to a more balanced R&D spend.
Adjusted EBITDA and EPS Improvement
Adjusted EBITDA was positive $2.1M in Q1, an improvement of $26M year-over-year (or $28.2M adjusted for divestitures). First quarter non-GAAP loss per share improved to a $0.01 loss versus a $0.21 loss a year ago.
Strong Cash Position and Balance Sheet Awareness
Ended Q1 with $86.5M in total cash. Near-term debt of $3.9M due in Q4 2026 and remaining $92M maturing in 2030, providing runway while management focuses on disciplined capital allocation.
Manufacturing Capacity Expansion and Technology Investment
Announced 80,000 sq ft expansion at Littleton facility (grand opening late summer) to scale metal part production for aerospace customers. Continued product investments include a $28M government-supported development program for next-gen large-format metal printers.
Backlog and Raised Production Targets
Built a solid order backlog for the denture platform entering Q2 and raised internal production targets for the second half of the year based on early commercial success.
DDD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DDD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 11, 2026 | $2.51 | $3.11 | +23.90% |
Mar 09, 2026 | $1.96 | $2.51 | +28.06% |
Nov 04, 2025 | $2.62 | $2.60 | -0.76% |
Aug 11, 2025 | $1.76 | $2.28 | +29.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does 3D Systems Corp (DDD) report earnings?
3D Systems Corp (DDD) is schdueled to report earning on Aug 10, 2026, TBA (Confirmed).
What is 3D Systems Corp (DDD) earnings time?
3D Systems Corp (DDD) earnings time is at Aug 10, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DDD EPS forecast?
DDD EPS forecast for the fiscal quarter 2026 (Q2) is -0.05.
